Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tommy Alain

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Nature Communications|March 31, 2015
Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killingRozanne Arulanandam, Cory Batenchuk, Oliver Varette, et al.
Nature Immunology|April 5, 2016
S6K-STING interaction regulates cytosolic DNA-mediated activation of the transcription factor IRF3Fuan Wang, Tommy Alain, Kristy J Szretter, et al.
Nucleic Acids Research|January 5, 2021
mTORC1 promotes TOP mRNA translation through site-specific phosphorylation of LARP1Jian-Jun Jia, Roni M Lahr, Michael T Solgaard, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2022
SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translationZhang Xu, Jung-Hyun Choi, David L Dai, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2022
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screenZaid Taha, Rozanne Arulanandam, Glib Maznyi, et al.
ACS Infectious Diseases|October 18, 2021
Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of ConcernMadalina Elena Carter-Timofte, Rozanne Arulanandam, Naziia Kurmasheva, et al.
Nature Biomedical Engineering|November 28, 2024
Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic virusesReza Rezaei, Stephen Boulton, Mahsa Ahmadi, et al.
Nature Communications|October 22, 2020
Author Correction: SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarateDavid Olagnier, Ensieh Farahani, Jacob Thyrsted, et al.
Nature Communications|October 3, 2020
SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarateDavid Olagnier, Ensieh Farahani, Jacob Thyrsted, et al.
Nature Communications|May 15, 2024
Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathwaysNaziia Kurmasheva, Aida Said, Boaz Wong, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Nature Communications|March 31, 2015
Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killingRozanne Arulanandam, Cory Batenchuk, Oliver Varette, et al.
Nature Immunology|April 5, 2016
S6K-STING interaction regulates cytosolic DNA-mediated activation of the transcription factor IRF3Fuan Wang, Tommy Alain, Kristy J Szretter, et al.
Nucleic Acids Research|January 5, 2021
mTORC1 promotes TOP mRNA translation through site-specific phosphorylation of LARP1Jian-Jun Jia, Roni M Lahr, Michael T Solgaard, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2022
SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translationZhang Xu, Jung-Hyun Choi, David L Dai, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2022
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screenZaid Taha, Rozanne Arulanandam, Glib Maznyi, et al.
ACS Infectious Diseases|October 18, 2021
Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of ConcernMadalina Elena Carter-Timofte, Rozanne Arulanandam, Naziia Kurmasheva, et al.
Nature Biomedical Engineering|November 28, 2024
Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic virusesReza Rezaei, Stephen Boulton, Mahsa Ahmadi, et al.
Nature Communications|October 22, 2020
Author Correction: SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarateDavid Olagnier, Ensieh Farahani, Jacob Thyrsted, et al.
Nature Communications|October 3, 2020
SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarateDavid Olagnier, Ensieh Farahani, Jacob Thyrsted, et al.
Nature Communications|May 15, 2024
Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathwaysNaziia Kurmasheva, Aida Said, Boaz Wong, et al.
Pageof 11